False-Positive Rate in First-Trimester Screening Based on Ultrasound and Cell-Free DNA versus First-Trimester Combined Screening with Additional Ultrasound Markers | Zendy

Karl Oliver Kagan | Zendy; Vanessa Maier | Zendy; Jiri Sonek | Zendy; Harald Abele | Zendy; K. Lüthgens | Zendy; M. Schmid | Zendy; Philipp Wagner | Zendy; Markus Hoopmann | Zendy

Open Access

False-Positive Rate in First-Trimester Screening Based on Ultrasound and Cell-Free DNA versus First-Trimester Combined Screening with Additional Ultrasound Markers

Author(s) -

Karl Oliver Kagan,

Vanessa Maier,

Jiri Sonek,

Harald Abele,

K. Lüthgens,

M. Schmid,

Philipp Wagner,

Markus Hoopmann

Publication year - 2018

Publication title -

fetal diagnosis and therapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.976

H-Index - 60

eISSN - 1421-9964

pISSN - 1015-3837

DOI - 10.1159/000489121

Subject(s) - ductus venosus , medicine , trisomy , ultrasound , nuchal translucency measurement , obstetrics , cell free fetal dna , gynecology , pregnancy , nasal bone , aneuploidy , gestation , prenatal diagnosis , fetus , radiology , surgery , biology , biochemistry , genetics , gene , chromosome

To determine whether screening for trisomy 21 based on first-trimester combined screening (FTCS) with assessment of nasal bone (NB), tricuspid flow (TCF), and ductus venosus flow (DVF) results in similar false-positive rates compared to ultrasound and cell-free DNA (cfDNA) screening.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research